Bifidobacterium breve BBG-001 in very preterm infants: A randomised controlled phase 3 trial
published online Nov 25
K Costeloe, P Hardy, E Juszczak, M Wilks, MR Millar on behalf of The Probiotics in Preterm Infants Study Collaborative Group Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial Lancet 2015 published online Nov 25. http://dx.doi.org/10.1016/S0140-6736(15)01027-2
Probiotics for preterm neonates: What will it take to change clinical practice?
N Ofek Shlomai, G Deshpande, S Rao, S Patole Probiotics for preterm neonates: what will it take to change clinical practice? Neonatology 105 2013 64 70
Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants
WA Mihatsch, CP Braegger, T Decsi et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants Clin Nutr 31 2012 6 15
Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates
A Bin-Nun, R Bromiker, M Wilschanski et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates J Pediatr 147 2005 192 196
Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants
HC Lin, BH Su, AC Chen et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants Pediatrics 115 2005 1 4
Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns
M Samanta, M Sarkar, P Ghosh, J Ghosh, M Sinha, S Chatterjee Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns J Trop Pediatr 55 2009 128 131
Probiotic effects on late-onset sepsis in very preterm infants: A randomized controlled trial
SE Jacobs, JM Tobin, GF Opie et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial Pediatrics 132 2013 1055 1062
US Food and Drug Administration Recall - firm press release. Solgar, INC. Issues Voluntary Class I Recall Of ABC Dophilus® Powder http://www.fda.gov/Safety/Recalls/ucm423219.htm (accessed Nov 20, 2015).
Notes from the field: Fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement-Connecticut, 2014
S Vallabhaneni, TA Walker, SR Lockhart et al. Notes from the field: fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement-Connecticut, 2014 MMWR Morb Mortal Wkly Rep 64 2015 155 156